China NMPA Product Recall - femoral head

The National Medical Products Administration (NMPA) announced a Level III voluntary product recall initiated by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. This regulatory action, documented under Index No. JGXX-2020-10004 and dated January 3, 2020, pertains to specific batches of the company's Femoral Head Diaphragm products. A Level III recall indicates that the use of or exposure to the affected product is not likely to cause adverse health consequences. While the exact issues necessitating this recall are detailed in an accompanying "Medical Device Recall Event Report Form," the announcement confirms the company's proactive measure to address potential concerns with the medical device. The document does not specify any particular inspection dates that directly led to this action. Under the NMPA's regulatory framework, Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. is required to execute this voluntary recall effectively. This entails ensuring all affected units of the Femoral Head Diaphragm are appropriately managed according to regulatory protocols, including identification and removal of specified products from the market, and informing relevant stakeholders to safeguard public health and maintain medical device quality standards.